Marion Jacquin

665 total citations
16 papers, 340 citations indexed

About

Marion Jacquin is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Marion Jacquin has authored 16 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Immunology and 5 papers in Surgery. Recurrent topics in Marion Jacquin's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Research and Treatments (3 papers). Marion Jacquin is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Research and Treatments (3 papers). Marion Jacquin collaborates with scholars based in France, Spain and Argentina. Marion Jacquin's co-authors include Camille Chauvin, Cristina Muñoz‐Pinedo, Jean‐Ehrland Ricci, Ludivine A. Pradelli, Patrick Auberger, Mario Pende, Sandrine Marchetti, Marie Bénéteau, Olivier Adotévi and Laura Boullerot and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and British Journal of Cancer.

In The Last Decade

Marion Jacquin

16 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Jacquin France 8 161 156 128 68 56 16 340
Ana T. Nunes United States 11 275 1.7× 120 0.8× 81 0.6× 52 0.8× 70 1.3× 19 455
Francesca Sparano Italy 9 219 1.4× 113 0.7× 78 0.6× 65 1.0× 103 1.8× 19 369
Jodi A. McKenzie United States 8 121 0.8× 155 1.0× 81 0.6× 54 0.8× 73 1.3× 30 302
Sho Sato Japan 12 157 1.0× 117 0.8× 101 0.8× 81 1.2× 67 1.2× 32 411
Leutz Buon United States 10 133 0.8× 241 1.5× 56 0.4× 44 0.6× 29 0.5× 28 368
Ming Gu China 7 250 1.6× 84 0.5× 206 1.6× 27 0.4× 46 0.8× 12 381
Liling Qin China 10 158 1.0× 136 0.9× 119 0.9× 127 1.9× 47 0.8× 20 366
Katriana Nugent United States 8 202 1.3× 297 1.9× 109 0.9× 95 1.4× 61 1.1× 14 460
Mari Bunkholt Elstrand Norway 10 161 1.0× 157 1.0× 140 1.1× 79 1.2× 36 0.6× 11 392
Cuncai Dai China 7 202 1.3× 149 1.0× 173 1.4× 71 1.0× 47 0.8× 13 369

Countries citing papers authored by Marion Jacquin

Since Specialization
Citations

This map shows the geographic impact of Marion Jacquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Jacquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Jacquin more than expected).

Fields of papers citing papers by Marion Jacquin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Jacquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Jacquin. The network helps show where Marion Jacquin may publish in the future.

Co-authorship network of co-authors of Marion Jacquin

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Jacquin. A scholar is included among the top collaborators of Marion Jacquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Jacquin. Marion Jacquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Carpentier, Alain, François Ghiringhelli, Rénata Ursu, et al.. (2023). Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study.. Journal of Clinical Oncology. 41(16_suppl). 2005–2005. 6 indexed citations
2.
Vienot, Angélique, Olivier Adotévi, Marion Jacquin, et al.. (2022). A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study. Frontiers in Oncology. 12. 957580–957580. 20 indexed citations
3.
Nardin, Charlée, Caroline Laheurte, E. Puzenat, et al.. (2021). Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma. Journal of Investigative Dermatology. 142(2). 435–444. 13 indexed citations
4.
Royer, Bernard, Antonin Schmitt, Thierry Nguyen, et al.. (2020). Exposure‐response analysis of Raltitrexed assessing liver toxicity. British Journal of Clinical Pharmacology. 87(3). 1327–1337. 4 indexed citations
5.
Boullerot, Laura, Caroline Laheurte, Amandine Martin, et al.. (2020). Association of reinvigoration of circulating anti-telomerase CD4 Th1 response in cancer patients with anti-PD-1 response.. Journal of Clinical Oncology. 38(15_suppl). 3044–3044. 1 indexed citations
6.
Vuitton, Lucine, Aurélia Meurisse, Laurie Spehner, et al.. (2020). Treatment of advanced squamous-cell anal carcinoma. 27(9). 873–881. 1 indexed citations
7.
Laheurte, Caroline, Fabien Calcagno, Laura Boullerot, et al.. (2019). Metronomic cyclophosphamide induces regulatory T cells depletion and PSA‐specific T cells reactivation in patients with biochemical recurrent prostate cancer. International Journal of Cancer. 147(4). 1199–1205. 14 indexed citations
8.
Laheurte, Caroline, Magalie Dosset, Déwi Vernerey, et al.. (2019). Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer. British Journal of Cancer. 121(5). 405–416. 67 indexed citations
9.
10.
Picard, Émilie, Yann Godet, Caroline Laheurte, et al.. (2018). Circulating NKp46+Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer. OncoImmunology. 8(2). e1527498–e1527498. 29 indexed citations
11.
Kim, Stéfano, Damien Montange, Thierry Nguyen, et al.. (2017). A simple and fast LC–MS/MS method with a very high sensitivity for the measurement of raltitrexed in human plasma. Journal of Chromatography B. 1060. 240–246. 3 indexed citations
12.
Kim, Stéfano, Sophie Paget‐Bailly, Mathieu Messager, et al.. (2016). Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. European Journal of Surgical Oncology. 43(1). 218–225. 11 indexed citations
13.
14.
Jary, Marine, François Ghiringhelli, Marion Jacquin, et al.. (2014). Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer. Cancer Chemotherapy and Pharmacology. 74(1). 141–150. 6 indexed citations
15.
Grépin, Renaud, Marion Jacquin, Jérôme Durivault, et al.. (2011). Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines. Oncogene. 31(13). 1683–1694. 49 indexed citations
16.
Pradelli, Ludivine A., Marie Bénéteau, Camille Chauvin, et al.. (2009). Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene. 29(11). 1641–1652. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana T. Nunes Breakdown of academic impact, for papers by Francesca Sparano Breakdown of academic impact, for papers by Jodi A. McKenzie Breakdown of academic impact, for papers by Sho Sato Breakdown of academic impact, for papers by Leutz Buon Breakdown of academic impact, for papers by Ming Gu Breakdown of academic impact, for papers by Liling Qin Breakdown of academic impact, for papers by Katriana Nugent Breakdown of academic impact, for papers by Mari Bunkholt Elstrand Breakdown of academic impact, for papers by Cuncai Dai
Rankless by CCL
2026